SJ medical
1 / 5
Indocyanine green (lCG) is a near-infrared fluorescent dye. Protein-bound ICG can be excited by external light with a wavelength range of 750 ~ 810 nm, and emits near-infrared light with a wavelength of about 840nm. Its half-life in blood is about 3 ~ 5 minutes. After entering the blood and binding to protein, it is absorbed by liver cells, then enters the intestine through the biliary tract, and finally is excreted with feces.
This indocyanine green injection has passed double consistency evaluations, ensuring high purity, low impurity content, and optimized storage conditions. It provides stable and reliable diagnosis and treatment options for the medical community.
Indications: Detection of choroidal neovascularization, macular lesions, intraocular tumors, and retinal vascular lesions; Intraoperative staining of capsule and internal limiting membrane.
Advantages: Provides clear choroidal vascular images for accurate diagnosis. Helps identify and treat the capsule and internal limiting membrane more accurately during cataract and retinal surgeries.
Indications: Evaluation of liver reserve function, liver tumor image development, liver segment identification, biliary tract development, and bile leakage observation.
Advantages: Rapid, accurate, and safe method for evaluating liver reserve function. Enhances visibility of liver structures, improving surgical safety and precision.
Indications: Accurate localization of tumors, imaging of the lymphatic system, and assessment of blood supply.
Advantages: Intuitive judgment of targets via fluorescence signal, enhancing visibility during operations.
Our research and production include high-end medical devices (fluorescence imaging series), fluorescence contrast agents (ICG, targeted contrast agent series), and core components (fluorescence CMOS camera modules, endoscopes). These products are utilized in more than 500 large hospitals.
Focused on core technologies such as molecular fluorescence, Raman spectroscopy, AI, and computer-aided drug molecular design (CADD). Our mission is to become a global leader in molecular fluorescence technology through the synergy of medical devices and pharmaceuticals.
Recognized as a specialized and sophisticated enterprise, we hold 131 core invention patents and 7 US invention patents. Strategic partnerships have been established with international leading companies in Germany and Japan, serving over 10 overseas countries.
